Yale University

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

TitlePrognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
Publication TypeJournal Article
Year of Publication2009
AuthorsLanoy, Emilie, Margaret May, Amanda Mocroft, Andrew Phillip, Amy Justice, Geneviève Chêne, Hansjakob Furrer, Timothy Sterling, Antonella d'Arminio Monforte, Lluís Force, John Gill, Ross Harris, Robert S. Hogg, Jürgen Rockstroh, Mike Saag, Pavel Khaykin, Frank de Wolf, Jonathan A. C. Sterne, and Dominique Costagliola
Corporate Authorsantiretroviral therapy cohort collaboration(ART-CC)
JournalAIDS (London, England)
Volume23
Issue16
Pagination2199-208
Date Published2009 Oct 23
ISSN1473-5571
KeywordsAdolescent, Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Disease Progression, Drug Therapy, Combination, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prognosis, Risk Factors, RNA, Viral, Time Factors, Viral Load, Young Adult
AbstractCD4 cell count and plasma viral load are well known predictors of AIDS and mortality in HIV-1-infected patients treated with combination antiretroviral therapy (cART). This study investigated, in patients treated for at least 3 years, the respective prognostic importance of values measured at cART initiation, and 6 and 36 months later, for AIDS and death.
DOI10.1097/QAD.0b013e3283305a00
Alternate JournalAIDS

External Links